Role of Venetoclax in the Treatment of Relapsed and Refractory Multiple Myeloma
{{output}}
Biomarker-driven targeted therapies have been an area of exploration for innovative therapeutic options in oncology. B-cell lymphoma-2 (BCL-2) protein is an anti-apoptotic protein expressed on the clonal plasma cells in patients with multiple myeloma (MM). MM ... ...
